- Category
- Micro (2020-21)
- Udyam number
- UDYAM-OD-19-0004396

About Adequin Pharmaceutical Private Limited
Data last updated:
Adequin Pharmaceutical Private Limited is a private limited company based in Bhubaneswar, Odisha, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 December 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U51909OR2020PTC034988. Its GSTIN is 21AAUCA4654R1ZZ (Odisha).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹3.84 Lakh. It is led by directors Suresh Kumar Parida (Managing Director) and Nayana Parida.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No – 296 Jagamara Khandagiri, Bhubaneswar, Odisha, India – 751030.
As per the financials filed for FY 2025, the company reported a revenue of ₹29.04 Lakh, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹394 (net margin 0%) and EBITDA of ₹22,994 (EBITDA margin 0.8%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years.
As per MCA filings, the company has open charges of ₹15.56 Lakh on record.
Adequin Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-OD-19-0004396). For more details, the company can be reached via its website adequinpharma.com.
Company details
Recognitions & Rankings of Adequin Pharmaceutical
Contact details
Adequin Pharmaceutical Private Limited's registered office is in Bhubaneswar, Odisha. Its website is adequinpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No – 296 Jagamara Khandagiri, Bhubaneswar, Odisha, India – 751030
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Adequin Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Adequin Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Adequin Pharmaceutical Private Limited, buy the company report.
Financials of Adequin Pharmaceutical Private Limited
FY 2025 filings availableAdequin Pharmaceutical Private Limited reported revenue of ₹29.04 Lakh (up 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 22% over three years, including 14% growth in the latest year. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹22,994 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹394 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.8% | ||||
| Net Profit Margin | 0% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Adequin Pharmaceutical Private Limited, buy the company report.
Board of directors of Adequin Pharmaceutical Private Limited
Adequin Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nayana Parida | Director | 06 May 2022 | 4 Years 5 Months | Current |
| Suresh Kumar Parida | Managing Director | 03 Dec 2020 | 5 Years 10 Months | Current |
Peer comparison
Adequin Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| PVM Import Export Private Limited | ₹29.06 Lakh (FY 2020) | Dist.: Ahmedabad, Gujarat, India | ||||
| Gupta Prakashan Private Limited | ₹29.06 Lakh (FY 2025) | -29.0% | New Delhi, Delhi, India | |||
| Optimus Tech Solutions Private Limited | ₹29.05 Lakh (FY 2024) | -38.0% | Faridabad, Haryana, India | |||
| Guruji RHM Infratech Private Limited | ₹29.05 Lakh (FY 2025) | 64.0% | Delhi, India | |||
| Maruti Stock Services Private Limited | ₹29.05 Lakh (FY 2020) | -26.0% | New Delhi, Delhi, India | |||
| Adequin Pharmaceutical Private Limitedthis company | ₹29.04 Lakh (FY 2025) | ₹394 | 0% | 14.0% | Bhubaneswar, Odisha, India | |
| Good Hew Meditech Private Limited | ₹29.04 Lakh (FY 2022) | -92.0% | Kochi, Kerala, India | |||
| A.K. Clothing Private Limited | ₹29.04 Lakh (FY 2024) | -49.0% | Mumbai, Maharashtra, India | |||
| Mydial Digital Led Ad Media Private Limited | ₹29.04 Lakh (FY 2017) | Nagpur, Maharashtra, India | ||||
| Hygitech Solutions Private Limited | ₹29.03 Lakh (FY 2024) | Gmc, Assam, India | ||||
| Freyr Pharma Private Limited | ₹29.03 Lakh (FY 2022) | Navi Mumbai, Maharashtra, India |
To see the full peer comparison of Adequin Pharmaceutical Private Limited, buy the company report.
Auditor
Adequin Pharmaceutical Private Limited is audited by JPMP & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JPMP & ASSOCIATES | FY 2023 | 0333001E |
Shareholding
The shareholding of Adequin Pharmaceutical Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Adequin Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Jan 2026 | 101223616 | Others | ₹15.56 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Adequin Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Adequin Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Adequin Pharmaceutical Private Limited has 1 active EPFO establishment as of Apr 09, 2024.
GST
Adequin Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AAUCA4654R1ZZ | Odisha | Active | 23 Feb 2021 |
To see the full GST registrations and return filing status of Adequin Pharmaceutical Private Limited, buy the company report.
Recent activity
Adequin Pharmaceutical Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Nayana Parida was appointed as Director on 06 May 2022.
Frequently asked questions
Adequin Pharmaceutical is an active private limited company based in Bhubaneswar, Odisha, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 December 2020 (6+ years old) and is registered under CIN U51909OR2020PTC034988.
Adequin Pharmaceutical has 2 current directors:
- Suresh Kumar Parida - Managing Director
- Nayana Parida - Director
The latest financial statements of Adequin Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Adequin Pharmaceutical is 21AAUCA4654R1ZZ, registered in Odisha.
The CIN (Corporate Identification Number) of Adequin Pharmaceutical is U51909OR2020PTC034988. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Adequin Pharmaceutical was incorporated on 03 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Cuttack.
The peers of Adequin Pharmaceutical by revenue are PVM Import Export Private Limited, Gupta Prakashan Private Limited, Optimus Tech Solutions Private Limited, Guruji RHM Infratech Private Limited, Maruti Stock Services Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Nayana Parida was appointed as Director on 06 May 2022. Rohit Parida ceased to be Director on 06 May 2022. Rohit Parida was appointed as Director on 03 Dec 2020. Adequin Pharmaceutical has 4 board changes on record in total.
Yes, Adequin Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-OD-19-0004396).
Adequin Pharmaceutical can be reached through the website adequinpharma.com. Its registered office is in Bhubaneswar, Odisha, India.
The registered office of Adequin Pharmaceutical is at Plot No – 296 Jagamara Khandagiri, Bhubaneswar, Odisha, India – 751030.